Manyoo Agarwal1, Sahil Agrawal2, Lohit Garg3, Guy L Reed4, Rami N Khouzam4, Uzoma N Ibebuogu4. 1. Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. 2. Division of Cardiovascular Medicine, Department of Internal Medicine, St Luke's University Health Network, Bethlehem, PA, USA. 3. Division of Cardiovascular Medicine, Department of Internal Medicine, Lehigh Valley Health Network, Allentown, PA, USA. 4. Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.
Abstract
BACKGROUND: The paradox that smokers have better clinical outcomes in cardiovascular diseases remains controversial. No literature exists studying impact of smoking on outcomes following transcatheter aortic valve replacement (TAVR). METHODS: We performed an electronic search of the 2011-2012 National Inpatient Sample (NIS) database to identify all TAVR hospitalizations. Outcomes were measured comparing smokers to non-smokers. RESULTS: A total of 8,345 TAVR hospitalizations were identified with 24% being smokers. Compared to non-smokers, smokers were younger (80.4±8.8 vs. 81.4±9.2 years, P<0.001), were more often men (63.6% vs. 47.8%, P<0.001), and had a higher disease burden. Despite a higher disease burden, smokers had lower post procedure stroke (2.8% vs. 3.1%), hemorrhage events (28.2% vs. 32.0%, P<0.05) and lower all cause in-hospital mortality (1.2% vs. 5.7%, adjusted odds ratio 0.21, 95% CI: 0.13-0.32, P<0.001) compared to non-smokers. CONCLUSIONS: Despite having a higher cardiovascular disease burden, smokers had better outcomes compared to non-smokers. Therefore the smoker's paradox is applicable in the TAVR cohort.
BACKGROUND: The paradox that smokers have better clinical outcomes in cardiovascular diseases remains controversial. No literature exists studying impact of smoking on outcomes following transcatheter aortic valve replacement (TAVR). METHODS: We performed an electronic search of the 2011-2012 National Inpatient Sample (NIS) database to identify all TAVR hospitalizations. Outcomes were measured comparing smokers to non-smokers. RESULTS: A total of 8,345 TAVR hospitalizations were identified with 24% being smokers. Compared to non-smokers, smokers were younger (80.4±8.8 vs. 81.4±9.2 years, P<0.001), were more often men (63.6% vs. 47.8%, P<0.001), and had a higher disease burden. Despite a higher disease burden, smokers had lower post procedure stroke (2.8% vs. 3.1%), hemorrhage events (28.2% vs. 32.0%, P<0.05) and lower all cause in-hospital mortality (1.2% vs. 5.7%, adjusted odds ratio 0.21, 95% CI: 0.13-0.32, P<0.001) compared to non-smokers. CONCLUSIONS: Despite having a higher cardiovascular disease burden, smokers had better outcomes compared to non-smokers. Therefore the smoker's paradox is applicable in the TAVR cohort.
Authors: Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas Journal: Circulation Date: 2014-03-03 Impact factor: 29.690
Authors: Akshat Saxena; Leonard Shan; Diem T Dinh; Julian A Smith; Gilbert C Shardey; Christopher M Reid; Andrew E Newcomb Journal: J Heart Valve Dis Date: 2013-03
Authors: Anna Kufner; Christian H Nolte; Ivana Galinovic; Peter Brunecker; Gerald M Kufner; Matthias Endres; Jochen B Fiebach; Martin Ebinger Journal: Stroke Date: 2013-01-03 Impact factor: 7.914
Authors: Tanush Gupta; Dhaval Kolte; Sahil Khera; Prakash Harikrishnan; Marjan Mujib; Wilbert S Aronow; Diwakar Jain; Ali Ahmed; Howard A Cooper; William H Frishman; Deepak L Bhatt; Gregg C Fonarow; Julio A Panza Journal: J Am Heart Assoc Date: 2016-04-22 Impact factor: 5.501
Authors: Dae Yong Park; Seokyung An; Jonathan M Hanna; Stephen Y Wang; Ana S Cruz-Solbes; Ajar Kochar; Angela M Lowenstern; John K Forrest; Yousif Ahmad; Michael Cleman; Abdulla Al Damluji; Michael G Nanna Journal: PLoS One Date: 2022-10-20 Impact factor: 3.752